82 FR 26211 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 82, Issue 107 (June 6, 2017)
Federal Motor Carrier Safety Administration
Federal Register Volume 82, Issue 107 (June 6, 2017)
| Page Range | 26211-26217 | |
| FR Document | 2017-11640 |
[Federal Register Volume 82, Number 107 (Tuesday, June 6, 2017)] [Notices] [Pages 26211-26217] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-11640] [[Page 26211]] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2017-0035] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 42 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before July 6, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2017-0035 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 42 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Shayne T. Anthony Mr. Anthony, 38, has had ITDM since 2006. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Anthony understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Anthony meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Maryland. Steven S. Arrowood Mr. Arrowood, 39, has had ITDM since 2001. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Arrowood understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Arrowood meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Mississippi. Melyssia V. Auwerda Ms. Auwerda, 28, has had ITDM since 2000. Her endocrinologist examined her in 2017 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Auwerda understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Auwerda meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class A CDL from Colorado. Jerome Barfield Mr. Barfield, 52, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Barfield understands diabetes management and monitoring, [[Page 26212]] has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Barfield meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Georgia. Grover C. Binkley Mr. Binkley, 49, has had ITDM since 2007. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Binkley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Binkley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Tennessee. Vincent Bongiovanni Mr. Bongiovanni, 47, has had ITDM since 1992. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bongiovanni understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bongiovanni meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Massachusetts. Robert H. Branyon Mr. Branyon, 63, has had ITDM since 2003. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Branyon understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Branyon meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class B CDL from South Carolina. Gary L. Brown Mr. Brown, 61, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Brown understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Brown meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Indiana. Douglas R. Carr Mr. Carr, 64, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carr understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carr meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from California. Gary F. Cartwright Mr. Cartwright, 65, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cartwright understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cartwright meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Jeffrey R. Cline Mr. Cline, 52, has had ITDM since 2010. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cline understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cline meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Cheryl L. Coffman Ms. Coffman, 50, has had ITDM since 2008. Her endocrinologist examined her in 2017 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Coffman understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Coffman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class B CDL from Indiana. Jay B. Cole Mr. Cole, 32, has had ITDM since 2016. His endocrinologist examined him [[Page 26213]] in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cole understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cole meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Nicholas B. Cooksey Mr. Cooksey, 23, has had ITDM since 1999. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cooksey understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cooksey meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from California. Michael Csaplik Mr. Csaplik, 62, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Csaplik understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Csaplik meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Karl J. Dence Mr. Dence, 48, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Dence understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dence meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New York. James R. Diem Mr. Diem, 65, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Diem understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Diem meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Mark W. Eaves Mr. Eaves, 49, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Eaves understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Eaves meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New York. Franklin J. Economy Mr. Economy, 62, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Economy understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Economy meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Ervin L. Elfman, Jr. Mr. Elfman, 79, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Elfman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Elfman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Kansas. Oliver L. Grigsby Mr. Grigsby, 59, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Grigsby understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Grigsby meets the requirements of the vision standard at [[Page 26214]] 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Virginia. Jason Hargrove Mr. Hargrove, 51, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hargrove understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hargrove meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable proliferative diabetic retinopathy. He holds a Class A CDL from North Carolina. Kevin J. Hart Mr. Hart, 63, has had ITDM since 1997. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hart understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hart meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from New York. Thomas R. Holland Mr. Holland, 24, has had ITDM since 1995. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Holland understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Holland meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Maryland. Martin J. Jones Mr. Jones, 52, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Jones understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Jones meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Massachusetts. Robert A. Kurley Mr. Kurley, 47, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kurley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kurley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Pennsylvania. Robert I. Leach Mr. Leach, 65, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Leach understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Leach meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Virginia. Mark A. Long Mr. Long, 56, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Long understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Long meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Micheal D. Lucas Mr. Lucas, 66, has had ITDM since 1998. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lucas understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lucas meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Dagmar L. Osoria Castaneda Mr. Osorio Castaneda, 31, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies [[Page 26215]] that Mr. Osorio Castaneda understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Osorio Castaneda meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from California. Roxanne Pierce Ms. Pierce, 62, has had ITDM since 1997. Her endocrinologist examined her in 2017 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Pierce understands diabetes management and monitoring, has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Pierce meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2017 and certified that she does not have diabetic retinopathy. She holds an operator's license from North Dakota. Garry B. Reynolds, Jr. Mr. Reynolds, 52, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Reynolds understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Reynolds meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class C CDL from Michigan. Jason R. Roberts Mr. Roberts, 38, has had ITDM since 1994. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Roberts understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Roberts meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class D CDL from Kentucky. Ronald H. Shepherd Mr. Shepherd, 41, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Shepherd understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Shepherd meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Randall D. Shiflett Mr. Shiflett, 52, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Shiflett understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Shiflett meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from West Virginia. Teddy D. Smith Mr. Smith, 50, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Oklahoma. Jonathan D. Snudden, Jr. Mr. Snudden, 48, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Snudden understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Snudden meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Missouri. Maleika A. Swain-Ogilvie Ms. Swain-Ogilvie, 38, has had ITDM since 2016. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Swain-Ogilvie understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Swain-Ogilvie meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class B CDL from Pennsylvania. Ashley D. Waite Mr. Waite, 64, has had ITDM since 2007. His endocrinologist examined him [[Page 26216]] in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Waite understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Waite meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Vermont. Delbert A. Walker Mr. Walker, 64, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Walker understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Walker meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Terry L. Watkins Mr. Watkins, 49, has had ITDM since 2008. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Watkins understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Watkins meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from West Virginia. Timothy Zulla Mr. Zulla, 54, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Zulla understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Zulla meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Florida. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C.. 31136(e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0035 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0035 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. [[Page 26217]] Issued on: May 26, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017-11640 Filed 6-5-17; 8:45 am] BILLING CODE 4910-EX-P
![Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices 26211
DEPARTMENT OF TRANSPORTATION acknowledgment that we received your requirements of the vision standard at
comments, please include a self- 49 CFR 391.41(b)(10). His
Federal Motor Carrier Safety addressed, stamped envelope or ophthalmologist examined him in 2017
Administration postcard or print the acknowledgement and certified that he does not have
[Docket No. FMCSA–2017–0035] page that appears after submitting diabetic retinopathy. He holds an
comments on-line. operator’s license from Maryland.
Qualification of Drivers; Exemption Privacy Act: In accordance with 5
Steven S. Arrowood
Applications; Diabetes Mellitus U.S.C. 553(c), DOT solicits comments
from the public to better inform its Mr. Arrowood, 39, has had ITDM
AGENCY: Federal Motor Carrier Safety rulemaking process. DOT posts these since 2001. His endocrinologist
Administration (FMCSA), DOT. comments, without edit, including any examined him in 2017 and certified that
ACTION: Notice of applications for personal information the commenter he has had no severe hypoglycemic
exemptions; request for comments. provides, to www.regulations.gov, as reactions resulting in loss of
described in the system of records consciousness, requiring the assistance
SUMMARY: FMCSA announces receipt of notice (DOT/ALL–14 FDMS), which can of another person, or resulting in
applications from 42 individuals for be reviewed at www.dot.gov/privacy. impaired cognitive function that
exemption from the prohibition against FOR FURTHER INFORMATION CONTACT: Ms. occurred without warning in the past 12
persons with insulin-treated diabetes Christine A. Hydock, Chief, Medical months and no recurrent (2 or more)
mellitus (ITDM) operating commercial Programs Division, (202) 366–4001, severe hypoglycemic episodes in the
motor vehicles (CMVs) in interstate fmcsamedical@dot.gov, FMCSA, last 5 years. His endocrinologist certifies
commerce. If granted, the exemptions Department of Transportation, 1200 that Mr. Arrowood understands diabetes
would enable these individuals with New Jersey Avenue SE., Room W64– management and monitoring, has stable
ITDM to operate CMVs in interstate 113, Washington, DC 20590–0001. control of his diabetes using insulin,
commerce. Office hours are 8:30 a.m. to 5 p.m., e.t., and is able to drive a CMV safely. Mr.
DATES: Comments must be received on Monday through Friday, except Federal Arrowood meets the requirements of the
or before July 6, 2017. holidays. vision standard at 49 CFR 391.41(b)(10).
His optometrist examined him in 2017
ADDRESSES: You may submit comments SUPPLEMENTARY INFORMATION:
and certified that he does not have
bearing the Federal Docket Management I. Background diabetic retinopathy. He holds an
System (FDMS) Docket No. FMCSA– operator’s license from Mississippi.
2017–0035 using any of the following Under 49 U.S.C. 31136(e) and 31315,
methods: FMCSA may grant an exemption from Melyssia V. Auwerda
• Federal eRulemaking Portal: Go to the Federal Motor Carrier Safety
Ms. Auwerda, 28, has had ITDM since
http://www.regulations.gov. Follow the Regulations for a 2-year period if it finds
2000. Her endocrinologist examined her
on-line instructions for submitting ‘‘such exemption would likely achieve a
in 2017 and certified that she has had
comments. level of safety that is equivalent to or
no severe hypoglycemic reactions
• Mail: Docket Management Facility; greater than the level that would be
resulting in loss of consciousness,
U.S. Department of Transportation, 1200 achieved absent such exemption.’’ The
requiring the assistance of another
New Jersey Avenue SE., West Building statute also allows the Agency to renew
person, or resulting in impaired
Ground Floor, Room W12–140, exemptions at the end of the 2-year
cognitive function that occurred without
Washington, DC 20590–0001. period. The 42 individuals listed in this
warning in the past 12 months and no
• Hand Delivery: West Building notice have recently requested such an
recurrent (2 or more) severe
Ground Floor, Room W12–140, 1200 exemption from the diabetes prohibition
hypoglycemic episodes in the last 5
New Jersey Avenue SE., Washington, in 49 CFR 391.41(b)(3), which applies to
years. Her endocrinologist certifies that
DC, between 9 a.m. and 5 p.m., e.t., drivers of CMVs in interstate commerce.
Ms. Auwerda understands diabetes
Monday through Friday, except Federal Accordingly, the Agency will evaluate
management and monitoring has stable
Holidays. the qualifications of each applicant to
control of her diabetes using insulin,
• Fax: 1–202–493–2251. determine whether granting the
and is able to drive a CMV safely. Ms.
Instructions: Each submission must exemption will achieve the required
Auwerda meets the requirements of the
include the Agency name and the level of safety mandated by statute.
vision standard at 49 CFR 391.41(b)(10).
docket numbers for this notice. Note II. Qualifications of Applicants Her ophthalmologist examined her in
that all comments received will be 2016 and certified that she does not
posted without change to http:// Shayne T. Anthony
have diabetic retinopathy. She holds a
www.regulations.gov, including any Mr. Anthony, 38, has had ITDM since Class A CDL from Colorado.
personal information provided. Please 2006. His endocrinologist examined him
see the Privacy Act heading below for in 2017 and certified that he has had no Jerome Barfield
further information. severe hypoglycemic reactions resulting Mr. Barfield, 52, has had ITDM since
Docket: For access to the docket to in loss of consciousness, requiring the 2016. His endocrinologist examined him
read background documents or assistance of another person, or in 2016 and certified that he has had no
comments, go to http:// resulting in impaired cognitive function severe hypoglycemic reactions resulting
www.regulations.gov at any time or that occurred without warning in the in loss of consciousness, requiring the
Room W12–140 on the ground level of past 12 months and no recurrent (2 or assistance of another person, or
mstockstill on DSK30JT082PROD with NOTICES
the West Building, 1200 New Jersey more) severe hypoglycemic episodes in resulting in impaired cognitive function
Avenue SE., Washington, DC, between 9 the last 5 years. His endocrinologist that occurred without warning in the
a.m. and 5 p.m., e.t., Monday through certifies that Mr. Anthony understands past 12 months and no recurrent (2 or
Friday, except Federal holidays. The diabetes management and monitoring, more) severe hypoglycemic episodes in
Federal Docket Management System has stable control of his diabetes using the last 5 years. His endocrinologist
(FDMS) is available 24 hours each day, insulin, and is able to drive a CMV certifies that Mr. Barfield understands
365 days each year. If you want safely. Mr. Anthony meets the diabetes management and monitoring,
VerDate Sep<11>2014 20:52 Jun 05, 2017 Jkt 241001 PO 00000 Frm 00170 Fmt 4703 Sfmt 4703 E:\FR\FM\06JNN1.SGM 06JNN1](https://thefederalregister.org/doc/82_FR_26318/page/1.svg)
![Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices 26217
Issued on: May 26, 2017. DEPARTMENT OF TRANSPORTATION rulemaking process. DOT posts these
Larry W. Minor, comments, without edit, including any
Associate Administrator for Policy. Federal Motor Carrier Safety personal information the commenter
[FR Doc. 2017–11640 Filed 6–5–17; 8:45 am] Administration provides, to http://www.regulations.gov,
BILLING CODE 4910–EX–P
as described in the system of records
[Docket No. FMCSA–2013–0109; FMCSA–
2013–0444] notice (DOT/ALL–14 FDMS), which can
be reviewed at http://www.dot.gov/
DEPARTMENT OF TRANSPORTATION Qualification of Drivers; Exemption privacy.
Applications; Epilepsy and Seizure II. Background
Federal Motor Carrier Safety Disorders
Administration On October 20, 2016, FMCSA
AGENCY: Federal Motor Carrier Safety published a notice announcing its
[Docket No. FMCSA–2007–28043] Administration (FMCSA), DOT. decision to renew exemptions for 10
Hours of Service (HOS) of Drivers; ACTION: Notice of final disposition. individuals from the Epilepsy and
American Pyrotechnics Assoc. (APA) Seizure Disorders prohibition in 49 CFR
SUMMARY: FMCSA confirms its decision 391.41(b)(8) to operate a CMV in
Application for Exemption From the to renew exemptions for 10 individuals
14-Hour Rule; Request To Add New interstate commerce and requested
from the requirement in the Federal comments from the public (81 FR
Member to Current APA Exemption; Motor Carrier Safety Regulations
Correction 72663). The public comment period
(FMCSRs) that interstate commercial ended on November 21, 2016, and one
AGENCY: Federal Motor Carrier Safety motor vehicle (CMV) drivers have ‘‘no comment was received on January 12,
Administration (FMCSA), DOT. established medical history or clinical 2017, FMCSA published a second notice
ACTION: Notice of application for an diagnosis of epilepsy or any other announcing its decision to renew
extension of exemption; request for condition which is likely to cause loss exemptions for the same 10 individuals
comments; correction. of consciousness or any loss of ability to from the Epilepsy and Seizure Disorders
control a CMV.’’ The exemptions enable prohibition in 49 CFR 391.41(b)(8) to
SUMMARY: The FMCSA published a these individuals who have had one or operate a CMV in interstate commerce
document in the Federal Register of more seizures and are taking anti- and requested comments from the
May 15, 2017 (82 FR 22375), concerning seizure medication to continue to public (81 FR 72663). The public
a request for comments on the American operate CMVs in interstate commerce. comment period ended on February 13,
Pyrotechnics Association’s request for a DATES: Each group of renewed 2017, and no comments were received.
member company, Pyro Shows of exemptions was effective on the dates As stated in the previous notice,
Alabama, Incorporated, to be included stated in the discussions below and will FMCSA has evaluated the eligibility of
in an existing exemption. The document expire on the dates stated in the these applicants and determined that
referenced June 14, 2017, in the DATES discussions below. renewing these exemptions would
section but did not specify the FOR FURTHER INFORMATION CONTACT: Ms. achieve a level of safety equivalent to or
significance of that date, which should Christine A. Hydock, Chief, Medical greater than the level that would be
have been the end of the comment Programs Division, (202) 366–4001, achieved by complying with the current
period. fmcsamedical@dot.gov, FMCSA, regulation 49 CFR 391.41(b)(8).
DATES: Comments must be received on Department of Transportation, 1200
The physical qualification standard
or before June 14, 2017. New Jersey Avenue SE., Room W64–
for drivers regarding epilepsy found in
FOR FURTHER INFORMATION CONTACT: For 224, Washington, DC 20590–0001.
49 CFR 391.41(b)(8) states that a person
information concerning this notice, Office hours are from 8:30 a.m. to 5
is physically qualified to drive a CMV
contact Mr. Thomas Yager, Chief, p.m., e.t., Monday through Friday,
if that person:
FMCSA Driver and Carrier Operations except Federal holidays. If you have
questions regarding viewing or Has no established medical history or clinical
Division; Office of Carrier, Driver and diagnosis of epilepsy or any other condition
Vehicle Safety Standards; Telephone: submitting material to the docket,
which is likely to cause the loss of
(614) 942–6477. Email: MCPSD@ contact Docket Services, telephone (202)
consciousness or any loss of ability to control
dot.gov. If you have questions on 366–9826. a CMV.
viewing or submitting material to the SUPPLEMENTARY INFORMATION:
docket, contact Docket Services, In addition to the regulations, FMCSA
I. Electronic Access has published advisory criteria to assist
telephone (202) 366–9826.
You may see all the comments online Medical Examiners in determining
SUPPLEMENTARY INFORMATION:
through the Federal Document whether drivers with certain medical
Correction Management System (FDMS) at: http:// conditions are qualified to operate a
1. In the Federal Register of May 15, www.regulations.gov. CMV in interstate commerce. [49 CFR
2017 (82 FR 22375), in FR Doc. 2017– Docket: For access to the docket to part 391, APPENDIX A TO PART 391—
09735, on page 22376, in the first read background documents or MEDICAL ADVISORY CRITERIA,
column, correct the DATES paragraph to comments, go to http:// section H. Epilepsy: § 391.41(b)(8),
read: www.regulations.gov and/or Room paragraphs 3, 4, and 5.]
W12–140 on the ground level of the
mstockstill on DSK30JT082PROD with NOTICES
DATES: Comments must be received III. Discussion of Comments
on or before June 14, 2017. West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m. In response to the October 20, 2016,
Issued on: May 30, 2017. and 5 p.m., e.t., Monday through Friday, notice, FMCSA received one comment
Larry W. Minor, except Federal holidays. in support of Mr. Troff receiving an
Associate Administrator for Policy. Privacy Act: In accordance with 5 exemption. No comments were received
[FR Doc. 2017–11650 Filed 6–5–17; 8:45 am] U.S.C. 553(c), DOT solicits comments in response to the January 12, 2017
BILLING CODE 4910–EX–P from the public to better inform its notice.
VerDate Sep<11>2014 20:52 Jun 05, 2017 Jkt 241001 PO 00000 Frm 00176 Fmt 4703 Sfmt 4703 E:\FR\FM\06JNN1.SGM 06JNN1](https://thefederalregister.org/doc/82_FR_26318/page/7.svg)
Document Created: 2017-06-06 06:21:15
Document Modified: 2017-06-06 06:21:15
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before July 6, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 82 FR 26211 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR